Lisa M. DeFrancesco - 28 Feb 2025 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, IR and Corp Comm
Signature
/s/ Lisa M. DeFrancesco
Issuer symbol
LXRX
Transactions as of
28 Feb 2025
Net transactions value
-$6,094
Form type
4
Filing time
03 Mar 2025, 16:30:24 UTC
Previous filing
18 Feb 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +24,673 24,673 28 Feb 2025 Direct F1
transaction LXRX Common Stock Tax liability $6,094 -9,096 -37% $0.6700 15,577 28 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -24,673 -33% 49,347 28 Feb 2025 Common Stock 24,673 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock.
F4 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.